可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Rose EA, Gelijns AC, Moskowitz AJ, et al. Longterm mechanical left ventricular assistance for endstage heart failure[J]. N Engl J Med, 2001, 345(20):1435-1443.
[2] Holman WL, Davies JE, Rayburn BK, et al. Treatment of endstage heart disease with outpatient ventricular assist devices[J]. Ann Thorac Surg, 2002, 73(5):1489-1493.
[3] Thohon V, Stetson SJ, Nagueh SF, et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakeyNoon left ventricular assist device: a comparative analysis with pulsatiletype devices[J]. J Heart Lung Transplant, 2005, 24(5):566-575.
[4] Goldstein AH, Monreal G, Kambara A, et al. Partial support with a centrifugal left ventricular assist device reduces myocardial oxygen consumption in chronic, ischemic heart failure[J]. J Card Fail, 2005, 11(2):142-151.
[5] Kambayashi Y, Nakao K, Kimura H.et al. Biological characterization of human brain natriuretic peptide (BNP)and rat BNP: specific actions of BNP[J].Biochem Biophys Res Commun, 1990, 173(2):599-605.
[6] Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel hormone in humans. Evidence for an exquisite dual natriuretic peptide system, artial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest,1991,87(4):1402-1412.
[7] Magovern GJ Jr, Christlieb IY, Kao RL, et al. Recovery of the failing canine heart with biventricular support in a previously fatal experimental model[J]. J Thorac Cardiovasc Surg, 1987, 94(5):656-663.